US Head of Healthcare Investigations Jay Dewald spoke with Law360 to discuss how the first half of 2023’s life sciences and healthcare rulings and lawsuits may evolve and accelerate throughout the rest of the year.
Dewald’s practice is focused on white collar criminal defense, crisis management, internal investigations and government investigations of whistleblower claims including Qui Tam lawsuits pursuant to the federal False Claims Act.